sdf-9

Caenorhabditis elegans

Predicted to enable protein tyrosine phosphatase activity. Involved in dauer larval development. Located in plasma membrane. Expressed in XXXL; XXXR; and head. Human ortholog(s) of this gene implicated in artery disease (multiple); proliferative diabetic retinopathy; and type 2 diabetes mellitus. Is an ortholog of human PTPN1 (protein tyrosine phosphatase non-receptor type 1).

eak-3

Caenorhabditis elegans

Expressed in XXXL and XXXR.

eak-6

Caenorhabditis elegans

Predicted to enable histone H2AXY142 phosphatase activity and protein tyrosine phosphatase activity. Involved in dauer larval development. Located in plasma membrane. Expressed in XXXL and XXXR.

Y71G12B.10

Caenorhabditis elegans

Predicted to enable hydroxymethylglutaryl-CoA lyase activity. Predicted to be involved in L-leucine catabolic process and ketone body biosynthetic process. Used to study 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Human ortholog(s) of this gene implicated in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Is an ortholog of human HMGCL (3-hydroxy-3-methylglutaryl-CoA lyase) and HMGCLL1 (3-hydroxy-3-methylglutaryl-CoA lyase like 1).

ZK909.3

Caenorhabditis elegans

Predicted to enable guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity. Is an ortholog of human HDDC3 (HD domain containing 3).

T27B7.9

Caenorhabditis elegans

Is affected by rrf-3; sin-3; and spr-1 based on RNA-seq studies.

Y42H9B.10

Caenorhabditis elegans

Is affected by chd-3; let-418; and lpd-3 based on RNA-seq studies.

K01G12.22

Caenorhabditis elegans

Is affected by adr-1; rde-3; and rrf-3 based on RNA-seq and microarray studies.

mau-3

Caenorhabditis elegans

pup-3

Caenorhabditis elegans

Predicted to enable poly(A) RNA polymerase activity. Predicted to be involved in RNA 3'-end processing.